共 29 条
- [27] RETRACTED: Dasatinib promotes TRAIL-mediated apoptosis by upregulating CHOP-dependent death receptor 5 in gastric cancer (Retracted article. See vol. 13, pg. 798, 2023) FEBS OPEN BIO, 2018, 8 (05): : 732 - 742
- [28] Phase II Trial of Mapatumumab, a Fully Human Agonist Monoclonal Antibody to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor 1 (TRAIL-R1), in Combination With Paclitaxel and Carboplatin in Patients With Advanced Non-Small-Cell Lung Cancer CLINICAL LUNG CANCER, 2014, 15 (03) : 188 - +